Global NASH Therapeutic Drugs Market Insights and Forecast to 2028

Q: How big is the nash therapeutic drugs market?

Market Analysis and Insights Global NASH Therapeutic Drugs MarketThe global NASH Therapeutic Drugs market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Vitamin E and Pioglitazone accounting for of the NASH Therapeutic Drugs global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Q: Who are the key players in the nash therapeutic drugs market?

Some of the key players are Allergan Plc (Tobira), Bristol–Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences Inc, Intercept Pharmaceuticals Inc, Zydus Cadila, Others.

Code: QYRE-Auto-6B6133

Report

January 2022

Pages:96

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Allergan Plc (Tobira)

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

Market Analysis and Insights: Global NASH Therapeutic Drugs Market

The global NASH Therapeutic Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Vitamin E and Pioglitazone accounting for % of the NASH Therapeutic Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.

China NASH Therapeutic Drugs market size is valued at US$ million in 2021, while the North America and Europe NASH Therapeutic Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe NASH Therapeutic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NASH Therapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NASH Therapeutic Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NASH Therapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NASH Therapeutic Drugs market.

Global NASH Therapeutic Drugs Scope and Market Size

NASH Therapeutic Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global NASH Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Vitamin E and Pioglitazone

Ocaliva

Elafibranor

Selonsertib and Cenicriviroc

Segment by Application

Hospital Pharmacy

Online Provider

Retail Pharmacy

BY COMPANY

Allergan Plc (Tobira)

Bristol Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences, Inc.

Intercept Pharmaceuticals, Inc.

Zydus Cadila

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Allergan Plc (Tobira)

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Vitamin E and Pioglitazone

1.2.3 Ocaliva

1.2.4 Elafibranor

1.2.5 Selonsertib and Cenicriviroc

1.3 Market by Application

1.3.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacy

1.3.3 Online Provider

1.3.4 Retail Pharmacy

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global NASH Therapeutic Drugs Market Perspective (2017-2028)

2.2 NASH Therapeutic Drugs Growth Trends by Region

2.2.1 NASH Therapeutic Drugs Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 NASH Therapeutic Drugs Historic Market Size by Region (2017-2022)

2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Region (2023-2028)

2.3 NASH Therapeutic Drugs Market Dynamics

2.3.1 NASH Therapeutic Drugs Industry Trends

2.3.2 NASH Therapeutic Drugs Market Drivers

2.3.3 NASH Therapeutic Drugs Market Challenges

2.3.4 NASH Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NASH Therapeutic Drugs Players by Revenue

3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2017-2022)

3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2017-2022)

3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue

3.4 Global NASH Therapeutic Drugs Market Concentration Ratio

3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2021

3.5 NASH Therapeutic Drugs Key Players Head office and Area Served

3.6 Key Players NASH Therapeutic Drugs Product Solution and Service

3.7 Date of Enter into NASH Therapeutic Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NASH Therapeutic Drugs Breakdown Data by Type

4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2017-2022)

4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2023-2028)

5 NASH Therapeutic Drugs Breakdown Data by Application

5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2017-2022)

5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America NASH Therapeutic Drugs Market Size (2017-2028)

6.2 North America NASH Therapeutic Drugs Market Size by Type

6.2.1 North America NASH Therapeutic Drugs Market Size by Type (2017-2022)

6.2.2 North America NASH Therapeutic Drugs Market Size by Type (2023-2028)

6.2.3 North America NASH Therapeutic Drugs Market Share by Type (2017-2028)

6.3 North America NASH Therapeutic Drugs Market Size by Application

6.3.1 North America NASH Therapeutic Drugs Market Size by Application (2017-2022)

6.3.2 North America NASH Therapeutic Drugs Market Size by Application (2023-2028)

6.3.3 North America NASH Therapeutic Drugs Market Share by Application (2017-2028)

6.4 North America NASH Therapeutic Drugs Market Size by Country

6.4.1 North America NASH Therapeutic Drugs Market Size by Country (2017-2022)

6.4.2 North America NASH Therapeutic Drugs Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe NASH Therapeutic Drugs Market Size (2017-2028)

7.2 Europe NASH Therapeutic Drugs Market Size by Type

7.2.1 Europe NASH Therapeutic Drugs Market Size by Type (2017-2022)

7.2.2 Europe NASH Therapeutic Drugs Market Size by Type (2023-2028)

7.2.3 Europe NASH Therapeutic Drugs Market Share by Type (2017-2028)

7.3 Europe NASH Therapeutic Drugs Market Size by Application

7.3.1 Europe NASH Therapeutic Drugs Market Size by Application (2017-2022)

7.3.2 Europe NASH Therapeutic Drugs Market Size by Application (2023-2028)

7.3.3 Europe NASH Therapeutic Drugs Market Share by Application (2017-2028)

7.4 Europe NASH Therapeutic Drugs Market Size by Country

7.4.1 Europe NASH Therapeutic Drugs Market Size by Country (2017-2022)

7.4.2 Europe NASH Therapeutic Drugs Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2017-2028)

8.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type

8.2.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2017-2022)

8.2.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2023-2028)

8.2.3 Asia-Pacific NASH Therapeutic Drugs Market Share by Type (2017-2028)

8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application

8.3.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2017-2022)

8.3.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2023-2028)

8.3.3 Asia-Pacific NASH Therapeutic Drugs Market Share by Application (2017-2028)

8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region

8.4.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2017-2022)

8.4.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America NASH Therapeutic Drugs Market Size (2017-2028)

9.2 Latin America NASH Therapeutic Drugs Market Size by Type

9.2.1 Latin America NASH Therapeutic Drugs Market Size by Type (2017-2022)

9.2.2 Latin America NASH Therapeutic Drugs Market Size by Type (2023-2028)

9.2.3 Latin America NASH Therapeutic Drugs Market Share by Type (2017-2028)

9.3 Latin America NASH Therapeutic Drugs Market Size by Application

9.3.1 Latin America NASH Therapeutic Drugs Market Size by Application (2017-2022)

9.3.2 Latin America NASH Therapeutic Drugs Market Size by Application (2023-2028)

9.3.3 Latin America NASH Therapeutic Drugs Market Share by Application (2017-2028)

9.4 Latin America NASH Therapeutic Drugs Market Size by Country

9.4.1 Latin America NASH Therapeutic Drugs Market Size by Country (2017-2022)

9.4.2 Latin America NASH Therapeutic Drugs Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2017-2028)

10.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type

10.2.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2017-2022)

10.2.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2023-2028)

10.2.3 Middle East & Africa NASH Therapeutic Drugs Market Share by Type (2017-2028)

10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application

10.3.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2017-2022)

10.3.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2023-2028)

10.3.3 Middle East & Africa NASH Therapeutic Drugs Market Share by Application (2017-2028)

10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country

10.4.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2017-2022)

10.4.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Allergan Plc (Tobira)

11.1.1 Allergan Plc (Tobira) Company Details

11.1.2 Allergan Plc (Tobira) Business Overview

11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction

11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.1.5 Allergan Plc (Tobira) Recent Developments

11.2 Bristol Myers Squibb

11.2.1 Bristol Myers Squibb Company Details

11.2.2 Bristol Myers Squibb Business Overview

11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction

11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.2.5 Bristol Myers Squibb Recent Developments

11.3 Galmed Pharmaceuticals

11.3.1 Galmed Pharmaceuticals Company Details

11.3.2 Galmed Pharmaceuticals Business Overview

11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction

11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.3.5 Galmed Pharmaceuticals Recent Developments

11.4 Genfit SA

11.4.1 Genfit SA Company Details

11.4.2 Genfit SA Business Overview

11.4.3 Genfit SA NASH Therapeutic Drugs Introduction

11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.4.5 Genfit SA Recent Developments

11.5 Gilead Sciences, Inc.

11.5.1 Gilead Sciences, Inc. Company Details

11.5.2 Gilead Sciences, Inc. Business Overview

11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction

11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.5.5 Gilead Sciences, Inc. Recent Developments

11.6 Intercept Pharmaceuticals, Inc.

11.6.1 Intercept Pharmaceuticals, Inc. Company Details

11.6.2 Intercept Pharmaceuticals, Inc. Business Overview

11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction

11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.6.5 Intercept Pharmaceuticals, Inc. Recent Developments

11.7 Zydus Cadila

11.7.1 Zydus Cadila Company Details

11.7.2 Zydus Cadila Business Overview

11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction

11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022)

11.7.5 Zydus Cadila Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Allergan Plc (Tobira)

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

List of Tables

Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Vitamin E and Pioglitazone

Table 3. Key Players of Ocaliva

Table 4. Key Players of Elafibranor

Table 5. Key Players of Selonsertib and Cenicriviroc

Table 6. Global NASH Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global NASH Therapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 8. Global NASH Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)

Table 9. Global NASH Therapeutic Drugs Market Share by Region (2017-2022)

Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 11. Global NASH Therapeutic Drugs Market Share by Region (2023-2028)

Table 12. NASH Therapeutic Drugs Market Trends

Table 13. NASH Therapeutic Drugs Market Drivers

Table 14. NASH Therapeutic Drugs Market Challenges

Table 15. NASH Therapeutic Drugs Market Restraints

Table 16. Global NASH Therapeutic Drugs Revenue by Players (2017-2022) & (US$ Million)

Table 17. Global NASH Therapeutic Drugs Revenue Share by Players (2017-2022)

Table 18. Global Top NASH Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2021)

Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2021

Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2017-2022)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service

Table 23. Date of Enter into NASH Therapeutic Drugs Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2017-2022)

Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2023-2028)

Table 29. Global NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 30. Global NASH Therapeutic Drugs Revenue Share by Application (2017-2022)

Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 32. Global NASH Therapeutic Drugs Revenue Share by Application (2023-2028)

Table 33. North America NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 34. North America NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 35. North America NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 36. North America NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 37. North America NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 38. North America NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 39. Europe NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 40. Europe NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 41. Europe NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 42. Europe NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 43. Europe NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 44. Europe NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 45. Asia Pacific NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 46. Asia Pacific NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 47. Asia Pacific NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 48. Asia Pacific NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 49. Asia Pacific NASH Therapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)

Table 50. Asia Pacific NASH Therapeutic Drugs Market Size by Region (2023-2028) & (US$ Million)

Table 51. Latin America NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 52. Latin America NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 53. Latin America NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 54. Latin America NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 55. Latin America NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 56. Latin America NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 57. Middle East and Africa NASH Therapeutic Drugs Market Size by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa NASH Therapeutic Drugs Market Size by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa NASH Therapeutic Drugs Market Size by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa NASH Therapeutic Drugs Market Size by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa NASH Therapeutic Drugs Market Size by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa NASH Therapeutic Drugs Market Size by Country (2023-2028) & (US$ Million)

Table 63. Allergan Plc (Tobira) Company Details

Table 64. Allergan Plc (Tobira) Business Overview

Table 65. Allergan Plc (Tobira) NASH Therapeutic Drugs Product

Table 66. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 67. Allergan Plc (Tobira) Recent Developments

Table 68. Bristol Myers Squibb Company Details

Table 69. Bristol Myers Squibb Business Overview

Table 70. Bristol Myers Squibb NASH Therapeutic Drugs Product

Table 71. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 72. Bristol Myers Squibb Recent Developments

Table 73. Galmed Pharmaceuticals Company Details

Table 74. Galmed Pharmaceuticals Business Overview

Table 75. Galmed Pharmaceuticals NASH Therapeutic Drugs Product

Table 76. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 77. Galmed Pharmaceuticals Recent Developments

Table 78. Genfit SA Company Details

Table 79. Genfit SA Business Overview

Table 80. Genfit SA NASH Therapeutic Drugs Product

Table 81. Genfit SA Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 82. Genfit SA Recent Developments

Table 83. Gilead Sciences, Inc. Company Details

Table 84. Gilead Sciences, Inc. Business Overview

Table 85. Gilead Sciences, Inc. NASH Therapeutic Drugs Product

Table 86. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 87. Gilead Sciences, Inc. Recent Developments

Table 88. Intercept Pharmaceuticals, Inc. Company Details

Table 89. Intercept Pharmaceuticals, Inc. Business Overview

Table 90. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product

Table 91. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 92. Intercept Pharmaceuticals, Inc. Recent Developments

Table 93. Zydus Cadila Company Details

Table 94. Zydus Cadila Business Overview

Table 95. Zydus Cadila NASH Therapeutic Drugs Product

Table 96. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2017-2022) & (US$ Million)

Table 97. Zydus Cadila Recent Developments

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NASH Therapeutic Drugs Market Share by Type: 2021 VS 2028

Figure 2. Vitamin E and Pioglitazone Features

Figure 3. Ocaliva Features

Figure 4. Elafibranor Features

Figure 5. Selonsertib and Cenicriviroc Features

Figure 6. Global NASH Therapeutic Drugs Market Share by Application: 2021 VS 2028

Figure 7. Hospital Pharmacy Case Studies

Figure 8. Online Provider Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. NASH Therapeutic Drugs Report Years Considered

Figure 11. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global NASH Therapeutic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global NASH Therapeutic Drugs Market Share by Region: 2021 VS 2028

Figure 14. Global NASH Therapeutic Drugs Market Share by Players in 2021

Figure 15. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2021

Figure 17. North America NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)

Figure 19. North America NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)

Figure 20. North America NASH Therapeutic Drugs Market Size Share by Country (2017-2028)

Figure 21. United States NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)

Figure 25. Europe NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)

Figure 26. Europe NASH Therapeutic Drugs Market Size Share by Country (2017-2028)

Figure 27. Germany NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific NASH Therapeutic Drugs Market Size Share by Region (2017-2028)

Figure 37. China NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)

Figure 45. Latin America NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)

Figure 46. Latin America NASH Therapeutic Drugs Market Size Share by Country (2017-2028)

Figure 47. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa NASH Therapeutic Drugs Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa NASH Therapeutic Drugs Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa NASH Therapeutic Drugs Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa NASH Therapeutic Drugs Market Size Share by Country (2017-2028)

Figure 53. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE NASH Therapeutic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 57. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 58. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 59. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 60. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 61. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 62. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2017-2022)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global NASH Therapeutic Drugs Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-6B6133

Global NASH Therapeutic Drugs Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions